Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04300231 · ClinicalTrials.gov registry record · Phase 3
Thoracic Epidural Analgesia Versus Rectus Sheath Block Versus Surgeon Infiltration With Liposomal Bupivacaine or Standard Bupivacaine for Post-Operative Pain Control After Cystectomy
A Phase 3 study, sponsored by Indiana University.
- Completed
- Registry status
- Phase 3
- Development phase
- 160
- Enrollment target
NCT04300231 is a Phase 3 study that has completed, run by Indiana University. The registered enrollment target is 160 participants.
The verdict
NCT04300231, a Phase 3 study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 160 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the difference between four different pain control methods in patients who will be having a cystectomy surgery (surgical removal of the bladder).
Interventions
- DRUG Liposomal bupivacaine
- DRUG epidural bupivacaine 0.05%
- DRUG bupivacaine 0.125%
- DRUG bupivacaine 0.5%
- DRUG /hydromorphone 0.05mg/ml
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2019-10-22 |
| Est. Completion | 2021-12-24 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04300231
The ClinicalTrials.gov registry entry for NCT04300231 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Liposomal bupivacaine is the first listed.
NCT04300231 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04300231 about?
NCT04300231 is a clinical study titled "Thoracic Epidural Analgesia Versus Rectus Sheath Block Versus Surgeon Infiltration With Liposomal Bupivacaine or Standard Bupivacaine for Post-Operative Pain Control After Cystectomy". The purpose of this study is to compare the difference between four different pain control methods in patients who will be having a cystectomy surgery (surgical removal of the bladder).
What is the current status of trial NCT04300231?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 160 participants. The study started on 2019-10-22. Estimated completion is 2021-12-24.
What interventions are being tested in trial NCT04300231?
The interventions under investigation include: Liposomal bupivacaine (DRUG), epidural bupivacaine 0.05% (DRUG), bupivacaine 0.125% (DRUG), bupivacaine 0.5% (DRUG), /hydromorphone 0.05mg/ml (DRUG).
Who is sponsoring clinical trial NCT04300231?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.